Brian L. Wilson
Brian L. Wilson
Stop FollowingBrian L. Wilson
View as an RSS Feed
View Brian L. Wilson's Articles BY TICKER:
AAPL,
ABIO,
ABT,
ACAD,
ACHN,
ACRX,
AEGR,
AEZS,
AFFY,
ALXA,
AMPE,
AMRN,
AMZN,
ANAC,
ANTH,
APPA.OB,
APPY,
ARAY,
ARIA,
ARNA,
ARQL,
ARRY,
ASTX,
ATHX,
ATRS,
AVEO,
BAC,
BBRY,
BCRX,
BHP,
BIIB,
BLRX,
BMRN,
C,
CBMX,
CELG,
CHTP,
CLDX,
CLSN,
CLVS,
CORT,
CPRX,
CRME,
CUR,
CVM,
CYCC,
CYNO,
CYTK,
DARA,
DCTH,
DIS,
DMPI.OB,
DNDN,
DSCO,
DVAX,
EDAP,
EXEL,
F,
FOLD,
FRX,
FURX,
GALT,
GE,
GSK,
GWAY,
HALO,
HPTX,
HZNP,
IBM,
IMGN,
INO,
INTC,
ISIS,
ITMN,
JNJ,
JPM,
KERX,
KO,
LLY,
LNG,
LON,
LPTN,
LXRX,
MAKO,
MDVN,
MNKD,
MRK,
MSLP.OB,
MYRX,
NAVB,
NPSP,
NSPH,
NVS,
NWBO,
OMER,
ONCY,
ONXX,
OPK,
OPXA,
ORCL,
OREX,
OSIR,
OSUR,
OXY,
PCRX,
PCYC,
PFE,
PGNX,
PPHM,
PTN,
QCOR,
REGN,
RIGL,
RMTI,
RPRX,
RPTP,
SCMP,
SDRL,
SGMO,
SKUL,
SLV,
SNGX.OB,
SPPI,
SPY,
SRPT,
STML,
STXS,
SUPN,
T,
THRX,
TKMR,
TLON.OB,
TTNP.OB,
VRTX,
VVUS,
WMT,
ZGNX,
ZIOP
- Intel Signals A Golden Age In Consumer Electronics
- Pacira's Flagship Drug Exparel Approved
- Ford Paves Its Own Road To Recovery
- Amazon: The Perfect Storm
- Apple: Recent Drop Is An Ideal Opportunity
- AT&T: Stagnant Company, Good Stock
- IBM Earnings Send Mixed Signals
- Several Upcoming Catalysts In Play For Halozyme Therapeutics
- Europe: Dead Money For Years To Come
- Agony From Lipitor's Expiration Won't Be Exclusive To Pfizer
- Big Red Flags For The Economy And America's Well-Being
- Johnson & Johnson: An Ideal 'Parking Spot' While Markets Convulse
- Greece Is Defaulting; Recession Is Imminent. Play Defense
- Want More Defense? Try Some Pizza
- Deflation and Uncertainty - Unnerving Signs For The Market
- The Laughable Track Record Of Finance Equity Analysts
- More Pain Is Coming To Equities
- Why You Need Dividends In The Scary Times Ahead: 5 Ideas
- Whether You Should Buy Oracle Before Earnings
- Forget The Lower Dividend, Coca-Cola Still Dominates The Beverage Industry
- The Eurozone Will Continue Collapsing: Buy Precious Metals To Profit
- General Electric By The Numbers
- Fundamental Factors Should Suppress Crude Prices Into 2012
- It's In China's Interests To Keep Italy Afloat
- Why U.S. Banks Won't Be Crushed By A Greek Default
- Some Healthcare Equities Getting Quite Expensive
- Ampio Pharmaceuticals: A Rare Under The Radar Opportunity In Healthcare
- 6 Deeply Undervalued Large Caps To Consider
- Afinitor Further Improves Novartis' Position In Oncology Medication
- Why The Bulls Aren't Finished Yet
- Abbott Labs: An Ideal Safe Haven With Large Yield
- Oracle And IBM: 2 Picks To Avoid The Consumer Market
